AbbVie (NYSE:ABBV) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $2.71,…
AbbVie (NYSE:ABBV) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.71, beating the consensus estimate of $2.66 by $0.05 per share. Revenue came in at $16.6B, beating the estimate of $16.4B.
AbbVie's stock moved following the earnings release. The stock currently trades at $216.45 with a market capitalization of $395.7B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NYSE · ABBV
$265.12
Unchanged: -$0.01 · 0.00%
Live quote updated
Keep reading
